ETUDE | PHASE | SITE |
---|---|---|
EF-32: Pivotal, Randomized, Open-Label Study of Optune® (Tumor Treating Fields, 200kHz) Concomitant With Radiation Therapy and Temozolomide for the Treatment of Newly Diagnosed Glioblastoma
Glioblastoma Multiforme
|
autre
|
CHUV
|
RESURGE: Randomized Controlled Comparative Phase II Trial on Surgery for Glioblastoma Recurrence
Gliobastome récidivant
|
II
|
CHUV
|